2016
DOI: 10.1136/bjophthalmol-2016-308370
|View full text |Cite
|
Sign up to set email alerts
|

Optical coherence tomography angiography in adult-onset foveomacular vitelliform dystrophy

Abstract: In patients with AFVD, OCT-A showed vascular network rarefaction with less blood vessels at the superficial and deep capillary plexuses, and the choriocapillaris layer. These vascular abnormalities may play a role in the pathogenesis or simply represent a consequence of material accumulation and reabsorption in AFVD. In two cases, the conventional imaging did not show clearly the neovascularisation due to masking effect of the subretinal vitelliform material, while OCT-A showed distinctly the CNV.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
20
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 25 publications
2
20
0
Order By: Relevance
“…SS-OCTA can also be used to reliably identify subclinical Type 1 CNV in asymptomatic eyes with the clinical diagnosis of “dry AMD”, also known as non-exudative intermediate AMD (Roisman, Zhang et al 2016). In addition, OCTA has been a useful tool for identifying the presence or absence of choroidal neovascularization in some masquerade conditions, such as adult-onset foveomacular vitelliform dystrophy (Querques, Zambrowski et al 2016) and central serous chorioretinopathy (Bonini Filho, de Carlo et al 2015). For NVAMD, OCT has served as a way to indirectly assess the levels of vascular endothelial growth factor (VEGF) by detecting the absence or presence of exudation or macular fluid.…”
Section: Review Of Clinical Studies Utilizing Octamentioning
confidence: 99%
“…SS-OCTA can also be used to reliably identify subclinical Type 1 CNV in asymptomatic eyes with the clinical diagnosis of “dry AMD”, also known as non-exudative intermediate AMD (Roisman, Zhang et al 2016). In addition, OCTA has been a useful tool for identifying the presence or absence of choroidal neovascularization in some masquerade conditions, such as adult-onset foveomacular vitelliform dystrophy (Querques, Zambrowski et al 2016) and central serous chorioretinopathy (Bonini Filho, de Carlo et al 2015). For NVAMD, OCT has served as a way to indirectly assess the levels of vascular endothelial growth factor (VEGF) by detecting the absence or presence of exudation or macular fluid.…”
Section: Review Of Clinical Studies Utilizing Octamentioning
confidence: 99%
“…OCT-A is able to detect flow movement by detecting erythrocyte motion thus overcoming the constraints of dyebased angiography. Given its high sensitivity, OCT-A may detect newly formed CNV that are not yet symptomatic and/or not well visualized in standard imaging [19,20,22,[24][25][26][27][28][29].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, RPE irregularities could be detected including irregular thickened RPE layer, and solitary or multiple RPE detachment(s) (PED). The atrophic stage of the disease is marked by diffuse disruption of the outer retinal layers including the external limiting membrane (ELM), inner segment/outer segment (IS/OS) photoreceptor junction, and marked atrophy or even disappearance of RPE cell layer [30,31].…”
Section: Best's Disease (Vitelliform Macular Dystrophy)mentioning
confidence: 99%
“…This peculiar configuration could be due to overcrowding of vessels being displaced by the vitelliform lesion, or due to compensatory dilatation of the para-macular vascular bed secondary to vessel rarefaction in the macula, with consequent increased blood flow. Likewise, the choriocapillaris shows vascular rarefaction with multiple hypointense flow-void areas, which could be explained by vascular impairment due to degenerative changes induced by mechanical compression or due to masking effect by the accumulating vitelliform material [30][31][32][33][34][35].…”
Section: Best's Disease (Vitelliform Macular Dystrophy)mentioning
confidence: 99%
See 1 more Smart Citation